611 related articles for article (PubMed ID: 14750579)
1. Impairments and Hansen's disease control in Rondônia state, Amazon region of Brazil.
De Oliveira CR; De Alencar Mde J; De Sena Neto SA; Lehman LF; Schreuder PA
Lepr Rev; 2003 Dec; 74(4):337-48. PubMed ID: 14750579
[TBL] [Abstract][Full Text] [Related]
2. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. III. Neural and other impairments.
Schreuder PA
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):170-81. PubMed ID: 9728449
[TBL] [Abstract][Full Text] [Related]
3. Delay in presentation, an indicator for nerve function status at registration and for treatment outcome--the experience of the Bangladesh Acute Nerve Damage Study cohort.
Nicholls PG; Croft RP; Richardus JH; Withington SG; Smith WC
Lepr Rev; 2003 Dec; 74(4):349-56. PubMed ID: 14750580
[TBL] [Abstract][Full Text] [Related]
4. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996.
Dasananjali K; Schreuder PA; Pirayavaraporn C
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751
[TBL] [Abstract][Full Text] [Related]
5. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.
van Brakel WH; Nicholls PG; Das L; Barkataki P; Suneetha SK; Jadhav RS; Maddali P; Lockwood DN; Wilder-Smith E; Desikan KV
Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033
[TBL] [Abstract][Full Text] [Related]
6. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up.
Richardus JH; Nicholls PG; Croft RP; Withington SG; Smith WC
Int J Epidemiol; 2004 Apr; 33(2):337-43. PubMed ID: 15082636
[TBL] [Abstract][Full Text] [Related]
7. Impairments in multibacillary leprosy; a study from Brazil.
Pimentel MI; Nery JA; Borges E; Gonçalves RR; Sarno EN
Lepr Rev; 2004 Jun; 75(2):143-52. PubMed ID: 15282965
[TBL] [Abstract][Full Text] [Related]
8. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. I. Overview of the study.
Schreuder PA
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):149-58. PubMed ID: 9728447
[TBL] [Abstract][Full Text] [Related]
9. Progress of impairment scores following commencement of chemotherapy in multibacillary leprosy patients.
Reed NK; van Brakel WH; Reed DS
Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):328-36. PubMed ID: 9401485
[TBL] [Abstract][Full Text] [Related]
10. Unexplained delayed nerve impairment in leprosy after treatment.
Rosenberg NR; Faber WR; Vermeulen M
Lepr Rev; 2003 Dec; 74(4):357-65. PubMed ID: 14750581
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in epidemiological factors associated with treatment completion status of leprosy patients in the most hyperendemic district of Nepal.
Kumar RB; Singhasivanon P; Sherchand JB; Mahaisavariya P; Kaewkungwal J; Peerapakorn S; Mahotarn K
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):334-9. PubMed ID: 15691132
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
Pandey A; Uddin MJ; Patel R
Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
[TBL] [Abstract][Full Text] [Related]
13. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
Kaur I; Dogra S; Kumar B; Radotra BD
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
[TBL] [Abstract][Full Text] [Related]
14. Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3).
Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
Lepr Rev; 2003 Dec; 74(4):311-8. PubMed ID: 14750576
[TBL] [Abstract][Full Text] [Related]
15. The relationship between detection delay and impairment in leprosy control: a comparison of patient cohorts from Bangladesh and Ethiopia.
Van Veen NH; Meima A; Richardus JH
Lepr Rev; 2006 Dec; 77(4):356-65. PubMed ID: 17343222
[TBL] [Abstract][Full Text] [Related]
16. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
[TBL] [Abstract][Full Text] [Related]
17. The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2).
Van Brakel WH; Anderson AM; Withington SG; Croft RP; Nicholls PG; Richardus JH; Smith WC
Lepr Rev; 2003 Dec; 74(4):300-10. PubMed ID: 14750575
[TBL] [Abstract][Full Text] [Related]
18. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
Kar HK; Sharma P
Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
[TBL] [Abstract][Full Text] [Related]
19. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. II. Reactions.
Schreuder PA
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):159-69. PubMed ID: 9728448
[TBL] [Abstract][Full Text] [Related]
20. Ocular manifestation in treated multibacillary Hansen's disease.
Parikh R; Thomas S; Muliyil J; Parikh S; Thomas R
Ophthalmology; 2009 Nov; 116(11):2051-7.e1. PubMed ID: 19766316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
